The Clark Group engages in new reaction discovery to enable the synthesis of novel pharmaceuticals and natural products. At the core of our research program is the development of selective transition metal-catalyzed reactions. Researchers will be involved in reaction discovery, ligand/catalyst synthesis, ligand/catalyst optimization, reaction optimization and reaction development with the ultimate goal of applying new organic transformations to complex molecule synthesis. Furthermore, we will engage in understanding the reactivity and selectivity principles guiding our reactions. This will facilitate the transformation of new reaction discovery into practical methods for modern organic synthesis.